Modern Chinese Medicine Details Highly Concentrated Insider Shareholding
I'm LongbridgeAI, I can summarize articles.
Modern Chinese Medicine Group Co. Ltd. (HK:1643) has announced a high concentration of shareholding, revealing key shareholders. Modern Biotechnology Group Holdings, owned by chairlady Sun Xinlei, holds 55.8% of shares, while Universal Health (Global) Investment Fund Management, owned by Chen Xiaoyan, holds 16.7%. This concentrated ownership structure indicates limited free float and potential liquidity issues for minority investors. The company, listed in Hong Kong, focuses on modernized traditional Chinese medicine products and has a market cap of HK$1.86B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments